Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Jefferies

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Obstetrics and Gynecology|December 1, 1976
The retained cervical stump. A 25-year experienceJ H Pratt, J A Jefferies
Gynecologic Oncology|September 28, 2000
Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancerC H Boardman, M J Webb, J A Jefferies
American Journal of Obstetrics and Gynecology|April 1, 1984
Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progenyR H Kaufman, K Noller, E Adam, et al.
Gynecologic Oncology|April 1, 1981
Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracilG D Malkasian, D G Decker, S J Green, et al.
Obstetrics and Gynecology|July 1, 1985
Effects of progestational agents in treatment of endometrial carcinomaK C Podratz, P C O'Brien, G D Malkasian, et al.
Cancer Treatment Reports|February 1, 1987
Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinomaJ H Edmonson, G W McCormack, J E Krook, et al.
Gynecologic Oncology|September 1, 1987
Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaJ H Edmonson, J E Krook, J F Hilton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinomaJ H Edmonson, T R Fleming, D G Decker, et al.
Cancer Treatment Reports|February 1, 1979
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual diseaseJ H Edmonson, T R Fleming, D G Decker, et al.
Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Obstetrics and Gynecology|December 1, 1976
The retained cervical stump. A 25-year experienceJ H Pratt, J A Jefferies
Gynecologic Oncology|September 28, 2000
Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancerC H Boardman, M J Webb, J A Jefferies
American Journal of Obstetrics and Gynecology|April 1, 1984
Upper genital tract abnormalities and pregnancy outcome in diethylstilbestrol-exposed progenyR H Kaufman, K Noller, E Adam, et al.
Gynecologic Oncology|April 1, 1981
Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracilG D Malkasian, D G Decker, S J Green, et al.
Obstetrics and Gynecology|July 1, 1985
Effects of progestational agents in treatment of endometrial carcinomaK C Podratz, P C O'Brien, G D Malkasian, et al.
Cancer Treatment Reports|February 1, 1987
Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinomaJ H Edmonson, G W McCormack, J E Krook, et al.
Gynecologic Oncology|September 1, 1987
Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaJ H Edmonson, J E Krook, J F Hilton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinomaJ H Edmonson, T R Fleming, D G Decker, et al.
Cancer Treatment Reports|February 1, 1979
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual diseaseJ H Edmonson, T R Fleming, D G Decker, et al.
Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.
Pageof 2